The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators

This publication has 57 references indexed in Scilit:

• Tamoxifen: a personal retrospective
  The Lancet Oncology, 2000
• The development of tamoxifen for breast cancer therapy: A tribute to the late Arthur L. Walpole
  Breast Cancer Research and Treatment, 1988
• Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
  Published by Elsevier ,1976
• Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor
  Published by Elsevier ,1975
• 243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma model
  Journal of Steroid Biochemistry, 1974
• THE INDUCTION OF OVULATION BY TAMOXIFEN
  BJOG: An International Journal of Obstetrics and Gynaecology, 1973
• Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels
  BMJ, 1973
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971
• A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATS
  Reproduction, 1967
• SYNTHETIC ŒSTROGENS IN MAMMARY CANCER
  The Lancet, 1949